Abstract
Histoplasmosis is an endemic disease in many regions of the United States. Physicians must be aware of the clinical syndromes and take advantage of epidemiologic clues when diagnosing histoplasmosis pericarditis. Clinicians must also be familiar with the uses and limitations of a battery of serologic and mycologic tests. Finally, further clinical trials are needed to study the role of antifungal therapy in the treatment of histoplasmosis pericarditis.
Original language | English (US) |
---|---|
Pages (from-to) | 223-226 |
Number of pages | 4 |
Journal | Cardiology in Review |
Volume | 14 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2006 |
Keywords
- Antifungal therapy
- Histoplasmosis
- Pericarditis
- Serologic tests
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine